v3.23.3
STOCK-BASED COMPENSATION (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]    
SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes the Company’s stock option activity during the nine months ended September 30, 2023:

 

       Weighted average     
   Options  

Exercise

price

   Remaining contractual life   Intrinsic value 
Outstanding at December 31, 2022   26,334   $707.63    6.53   $        - 
Granted   -    -    -    - 
Exercised   -    -    -    - 
Expired / Forfeited   (20)   770.40    -    - 
Outstanding at September 30, 2023   26,314   $707.59    4.74    - 
Exercisable at September 30, 2023   24,505    722.84    -    - 
Vested and expected to vest   26,314   $707.59    4.74    - 

The following table summarizes the Company’s stock option activity during the year ended December 31, 2022:

 

       Weighted average     
   Options  

Exercise

price

  

Remaining

contractual

life

  

Intrinsic

value

 
Outstanding at December 31, 2021   18,505   $576.70    6.00   $10,207,306 
Granted   9,535    928.11    8.34    - 
Exercised   -    -    -    - 
Expired / Forfeited   (1,706)   519.62    -    - 
Outstanding at December 31, 2022   26,334    707.63    6.53    - 
Exercisable at December 31, 2022   23,258    738.89    6.19    - 
Vested and expected to vest   26,334    707.63    6.53    - 
SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

The fair value of each stock option granted has been determined using the Black-Scholes option-pricing model. The material assumptions used in the Black-Scholes model in estimating the fair value of the options granted for the periods presented were as follows (there were no grants issued in 2023):

 

   Nine Months Ended
September 30, 2022
 
Exercise price  $ 103.20 - 1,507.20 
Expected stock price volatility   76.61 - 95.87%
Expected term (years)   5.19 - 10.00 
Risk-free interest rate   1.52% - 3.14%
Expected dividend yield   0.00%

The fair value of each stock option granted has been determined using the Black-Scholes option-pricing model. The material assumptions used in the Black-Scholes model in estimating the fair value of the options granted for the periods presented were as follows (there were no grants issued in 2021):

 

   December 31, 2022 
Exercise price  $102.00-1,507.20 
Expected stock price volatility   76.61% - 95.87%
Expected term (years)   5.19-10.00 
Risk-free interest rate   1.52% - 3.14%
Expected dividend yield   0%
SCHEDULE OF RESTRICTED STOCK UNITS

The following table summarizes the Company’s restricted stock units activity during the nine months ended September 30, 2023:

 

   

Restricted Stock

Units

  

Weighted average fair

value

 
Outstanding at December 31, 2022    1,003   $120.02 
Released    (938)   101.40 
Cancelled    (2)   386.40 
Outstanding at September 30, 2023    63   $388.80 

The following table summarizes the Company’s restricted stock units activity during the year ended December 31, 2022:

 

  

Restricted

Stock Units

  

Weighted

average fair

value

 
Outstanding at December 31, 2021   -   $- 
Granted   5,320    215.22 
Released   (3,485)   294.29 
Cancelled   (832)   - 
Outstanding at December 31, 2022   1,003   $120.02 
SCHEDULE OF COMMON STOCK FUTURE ISSUANCE

The following shares of common stock are reserved for future issuance:

 

   September 30, 2023 
Awards outstanding under the 2021 Omnibus Incentive Plan   26,377 
Awards available for future grant under 2021 Omnibus Incentive Plan   617,112 
Warrants outstanding   4,929,996 
Total shares of common stock reserved for future issuance   5,573,485 

The following shares of common stock are reserved for future issuance:

 

   December 31, 2022 
Awards outstanding under the 2021 Omnibus Incentive Plan   27,337 
Awards available for future grant under 2021 Omnibus Incentive Plan   4,569 
2022 Notes outstanding   162,232 
Warrants outstanding   668,970 
Total shares of common stock reserved for future issuance   863,108